Singapore’s Lee & Lee and Atlanta firm Troutman Sanders have advised on a Singaporean company’s buyout of its Chinese partner’s stake in a joint venture to produce medical devices.
Investment holding company Biosensors International Group will pay $550 million for the 50 percent interest it does not already own in JW Medical Systems Ltd., a producer of drug-eluting stents–implants designed to release drugs slowly into the bloodstream. The company is based in Weihai, China.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
